Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeLatest newsJohnson & Johnson leaders make Fortune‘s 2017 Most Powerful Women list
      Johnson & Johnson’s Sandi Peterson (left) and Jennifer Taubert from Fortune's 2017 Most Powerful Women List

      Johnson & Johnson leaders make Fortune‘s 2017 Most Powerful Women list

      Group Worldwide Chair Sandi Peterson and Company Group Chairman, Pharmaceuticals, The Americas Jennifer Taubert are honorees once again this year.

      Share Article
      share to

      Two of Johnson & Johnson’s top leaders have made Fortune magazine’s list of Most Powerful Women: Group Worldwide Chair Sandi Peterson and Company Group Chairman, Pharmaceuticals, The Americas Jennifer Taubert—both of whom made the 2016 list.

      Each year since 1998, Fortune has highlighted 50 women who are leading in their industries—and transforming their businesses along the way.

      Peterson, who has appeared on the prestigious list five times and secured the #22 ranking this year, recently expanded her role at Johnson & Johnson to include oversight of the company’s hospital medical devices business, in addition to her existing responsibilities overseeing consumer and consumer medical devices, global design, global services, health technology, health & wellness, information technology and supply chain.

      The secret to her success? In a word, “optimism.”

      Since Johnson & Johnson was founded, women have been at the center of the story. More than half of the initial 14 employees were female, and today we have a vibrant, diverse group of leaders across our enterprise.
      Jennifer Taubert

      “It’s not in my DNA to say we can’t, we don’t, we’ve never,” Peterson says. “To be bold and make a difference, we need to experiment, test and learn, and do things differently. I think the most important lesson I’ve learned over the course of my career is the importance of intellectual curiosity, agility of learning, and relying on other people and figuring out how to get the best out of them.”

      Since debuting on last year’s list, Taubert—who oversees innovation-based growth from Canada to South America for the company’s pharmaceutical division—spearheaded the release of the company’s 2016 U.S. Transparency Report, which sought to address questions about drug pricing and other company practices. She has also been named by the National Association for Female Executives (NAFE) as a 2017 NAFE Woman of Excellence in honor of her career success and her efforts to boost the progress of women and girls.

      To Taubert, who nabbed the #43 ranking this year, it makes sense that more than one company leader is being feted by Fortune.

      “Since Johnson & Johnson was founded, women have been at the center of the story,” she points out. “More than half of the initial 14 employees were female, and today we have a vibrant, diverse group of leaders across our enterprise. Our representation on the list is an extraordinary hallmark in our continued efforts to ensure that Johnson & Johnson embodies diversity and inclusion in all that we do.”

      Powerful Women—and Powerful Mentors

      Learn how Peterson and Taubert are nurturing the next generation of global women leaders in this video.

      More from Johnson & Johnson

      Meet a nurse who leads clinical trials to find innovative cancer therapies

      Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.